Boc-N-α-Methyl-L-isoleucine

Boc-N-α-Methyl-L-isoleucine is a Boc-protected, α-methylated amino acid building block derived from L-isoleucine, designed to introduce steric bulk and conformational bias at the peptide backbone. The α-methyl substitution increases substitution at the amide-forming center, making it a useful residue for constructing peptides with altered secondary-structure preferences and improved resistance to backbone conformational flexibility. Its Boc group provides a standard, acid-labile N-terminus protection strategy commonly used in peptide synthesis workflows.

1. Sterically Biased Peptide Building

Boc-N-α-Methyl-L-isoleucine is used by peptide chemists to incorporate an α-methylated isoleucine residue into sequence-defined peptides where backbone sterics and local conformational constraints are desired. Researchers developing structure-activity relationship (SAR) libraries frequently select α-methyl amino acid building blocks to modulate helix/turn propensity and to tune the presentation of side-chain functionality while maintaining a protected, synthesis-ready amino acid format. This residue is particularly relevant in custom peptide synthesis and medicinal chemistry programs aiming to systematically compare analogs that differ at the backbone substitution level.

2. Fmoc-Free Segment Coupling

Boc-N-α-Methyl-L-isoleucine is commonly handled in protected-amino-acid assembly strategies that rely on Boc-compatible peptide coupling and deprotection cycles, including segment condensation approaches used in both academic and industrial peptide manufacturing. The presence of the Boc-protected nitrogen supports the preparation of well-defined peptide intermediates, enabling downstream coupling to neighboring residues with controlled N-terminus activation. Teams working on longer peptide assembly often value such Boc-protected amino acid building blocks when they are aligning a synthesis plan around Boc deprotection steps and orthogonal protection schemes already established in their workflow.

3. Medicinal Chemistry SAR Analog Synthesis

Boc-N-α-Methyl-L-isoleucine supports medicinal chemistry efforts that require rapid generation of peptide analogs with backbone modifications rather than side-chain changes. By installing an α-methylated version of an isoleucine-derived residue, developers can create series of analogs to probe how backbone substitution influences peptide behavior in assays focused on chemical stability, structure, and binding-competitor profiles. In this context, the building block format is selected to provide a reliable, protected amino acid unit that can be incorporated into peptide-like leads during iterative design and optimization.

4. Peptide Macrocycle And Constraint Design

Boc-N-α-Methyl-L-isoleucine is used in the synthesis of constrained peptide architectures, including macrocycles and other topologically restricted constructs, where controlling backbone geometry is essential for achieving the intended three-dimensional shape. The α-methyl group adds steric and conformational features at the residue level, which can help bias folding pathways and reduce conformational entropy in cyclic or otherwise constrained systems. Research groups building constrained peptide scaffolds for chemical biology tool development or lead optimization often choose α-methyl amino acid building blocks to create analogs with systematically varied backbone constraint strength while keeping the side-chain identity consistent.

1. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs

2. Multifunctional peptide-oligonucleotide conjugate promoted sensitive electrochemical biosensing of cardiac troponin I

3. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

4. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die

5. TMEM16F and dynamins control expansive plasma membrane reservoirs